These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15071360)

  • 1. Electropharmacological and proarrhythmic effects of a class III antiarrhythmic drug nifekalant hydrochloride assessed using the in vivo canine models.
    Satoh Y; Sugiyama A; Takahara A; Chiba K; Hashimoto K
    J Cardiovasc Pharmacol; 2004 May; 43(5):715-23. PubMed ID: 15071360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative lusitropic property of nifekalant identified using ventricular pressure-volume loop analyses in anesthetized monkeys.
    Ishizaka T; Yoshimatsu Y; Maeda Y; Chiba K; Mori K
    Exp Anim; 2019 Feb; 68(1):91-102. PubMed ID: 30333366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs.
    Motokawa Y; Nakamura Y; Hagiwara-Nagasawa M; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Ando K; Naito AT; Yamazaki H; Sugiyama A
    Cardiovasc Toxicol; 2018 Jun; 18(3):242-251. PubMed ID: 29139031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular block heart.
    Takahara A; Nakamura H; Nouchi H; Tamura T; Tanaka T; Shimada H; Tamura M; Tsuruoka N; Takeda K; Tanaka H; Shigenobu K; Hashimoto K; Sugiyama A
    J Pharmacol Sci; 2007 Feb; 103(2):181-8. PubMed ID: 17287589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn J Pharmacol; 1999 Sep; 81(1):79-85. PubMed ID: 10580374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the ATP-sensitive K⁺ channel opener nicorandil in a canine model of proarrhythmia.
    Watanabe I; Okumura Y; Ohkubo K; Nagashima K; Mano H; Sonoda K; Kofune M; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2011; 52(5):318-22. PubMed ID: 22008444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model.
    Sugiyama A; Satoh Y; Hashimoto K
    Jpn J Pharmacol; 2001 Sep; 87(1):74-82. PubMed ID: 11676202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetized beagle dogs.
    Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    J Toxicol Sci; 2016; 41(3):439-47. PubMed ID: 27193735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
    Sugiyama A
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):393-400. PubMed ID: 12835533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: potential utility of mexiletine for the treatment of drug-induced long QT syndrome.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn J Pharmacol; 2000 Aug; 83(4):327-34. PubMed ID: 11001179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electropharmacological effects of a spironolactone derivative, potassium canrenoate, assessed in the halothane-anesthetized canine model.
    Sugiyama A; Satoh Y; Takahara A; Ando K; Wang K; Honsho S; Nakamura Y; Hashimoto K
    J Pharmacol Sci; 2004 Dec; 96(4):436-43. PubMed ID: 15599107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias.
    Hashimoto K; Haruno A; Hirasawa A; Awaji T; Xue Y; Wu Z
    Jpn J Pharmacol; 1995 May; 68(1):1-9. PubMed ID: 7494370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
    Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring.
    Satoh Y; Sugiyama A; Chiba K; Tamura K; Hashimoto K
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):510-5. PubMed ID: 11026654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antipsychotic and antiemetic drug prochlorperazine delays the ventricular repolarization of the in situ canine heart.
    Satoh Y; Sugiyama A; Takahara A; Ando K; Wang K; Honsho S; Hashimoto K
    J Pharmacol Sci; 2005 Jan; 97(1):101-6. PubMed ID: 15655290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cardiac α
    Kawakami S; Kambayashi R; Takada K; Aimoto M; Nagasawa Y; Takahara A
    J Pharmacol Sci; 2022 Oct; 150(2):67-73. PubMed ID: 36055753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.